Abstract CT216: A Phase 1/2 Study of INCB000928 as Monotherapy or in Combination with Ruxolitinib in Patients with Anemia Due to Myelofibrosis (INCB 00928-104)
Year: 2021
Type: conference-abstract
Source: Cancer Research
Institutions: Washington University in St. Louis, Assistance Publique – Hôpitaux de Paris, Hôpital Saint-Louis, University of Bologna, Stanford Cancer Institute, Stanford University, Vanderbilt University Medical Center, City Of Hope National Medical Center, Incyte (United States), The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3173269612